Explore the preclinical research catching our eye in September 2026, from siRNA and in vivo CRISPR to targeted protein ...
Take a look at the Eli Lilly pipeline in 2026 as the incretin franchise grows and fuels the rest of the company's pipeline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results